Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Ahy3g2033 | ATGGGAAGAAGCCCTTGTTGCTCAAAGGAGGGTTTGAACCGCGGTGCCTGGACAGCTCAAGAAGACAAAATCCTCAGAGATTATATCAGTCTCCATGGCCAAGGAAAATGGAGGAACCTTCCTCAAAGAGCAGGGTTGAAACGTTGTGGGAAAAGTTGCAGGCTTCGATGGTTAAATTATCTGAGGCCAGATATTAAAAGAGGAAACATATCAGAAGATGAAGAAGAACTTATCATAAGACTTCACAAGCTACTTGGAAACAGATGGTCACTTATAGCCGGGAGGCTTCCAGGAAGAACAGACAATGAGATCAAGAATTATTGGAACACAAATTTAGGCAAAAGAGTTAGAGATCTTCAAACAATAAGCAGTGCATCTTCTCAGCAACCCAATGAAACAAATAACAACATTCAGAAACCAACAACAATGCCTCCTACAACCAATAAAGTGGTCTCCACAACCACTCCCTCTCTGTCACCGTTAAACGATTCACATTCTCTTCTCGTCCGTACAAAAGCTTCTAAGTGCTCTAAGTCATTATTCTTGGATCATTCATCAACAACAACAACTTCACTGCAGCAGAACAAGACTTCTAGTAATAATAATAATAATAATGACAATAGCCACGAACTCGATGAAACCGCCGCCGATCATGTTTTGCTGCCACCGCCGGGGTTGTTGCTTCCGAGCAACGGTGACAACAACAACACCATGGTGATGATGATGATGGAGATGGGTACCAATTCAGAAGAATACAAAGAGATCTCGACAACAGAATTGCTCTTGGATTTTGACGTTGGCGATATTTGCTTGCATTCTCTTCTGAACTCGGATTTCGAGGATATATGCGATTTCGGTTACAACAACAGTAACAGTAACTGCGAGGATCTGTTTGGATTCTCACCGCCGGAGCAGATGCAGCTGGATTCTTCTGATGAAGTTCTAAAGGAAGCCACCGTACCAAGCAACTTCCCTGACGAAACAAATAATATTGTACAAAACATACAGTTTCTGTGA | 1017 | 0.4228 | MGRSPCCSKEGLNRGAWTAQEDKILRDYISLHGQGKWRNLPQRAGLKRCGKSCRLRWLNYLRPDIKRGNISEDEEELIIRLHKLLGNRWSLIAGRLPGRTDNEIKNYWNTNLGKRVRDLQTISSASSQQPNETNNNIQKPTTMPPTTNKVVSTTTPSLSPLNDSHSLLVRTKASKCSKSLFLDHSSTTTTSLQQNKTSSNNNNNNDNSHELDETAADHVLLPPPGLLLPSNGDNNNTMVMMMMEMGTNSEEYKEISTTELLLDFDVGDICLHSLLNSDFEDICDFGYNNSNSNCEDLFGFSPPEQMQLDSSDEVLKEATVPSNFPDETNNIVQNIQFL* | 339 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Ahy3g2033 | 338 | ProSiteProfiles | Myb-type HTH DNA-binding domain profile. | 9 | 61 | IPR017930 | - | |
Ahy3g2033 | 338 | MobiDBLite | consensus disorder prediction | 186 | 210 | - | - | |
Ahy3g2033 | 338 | ProSiteProfiles | Myb-like domain profile. | 62 | 112 | IPR001005 | - | |
Ahy3g2033 | 338 | PANTHER | TRANSCRIPTION FACTOR MYB51-LIKE ISOFORM X1 | 1 | 246 | - | - | |
Ahy3g2033 | 338 | MobiDBLite | consensus disorder prediction | 123 | 163 | - | - | |
Ahy3g2033 | 338 | CDD | SANT | 16 | 61 | IPR001005 | - | |
Ahy3g2033 | 338 | Gene3D | - | 70 | 142 | - | - | |
Ahy3g2033 | 338 | ProSiteProfiles | Myb-like domain profile. | 9 | 61 | IPR001005 | - | |
Ahy3g2033 | 338 | ProSiteProfiles | Myb-type HTH DNA-binding domain profile. | 62 | 116 | IPR017930 | - | |
Ahy3g2033 | 338 | MobiDBLite | consensus disorder prediction | 186 | 209 | - | - | |
Ahy3g2033 | 338 | Pfam | Myb-like DNA-binding domain | 14 | 61 | IPR001005 | - | |
Ahy3g2033 | 338 | Pfam | Myb-like DNA-binding domain | 67 | 112 | IPR001005 | - | |
Ahy3g2033 | 338 | PANTHER | TRANSCRIPTION FACTOR MYB51-LIKE ISOFORM X1 | 1 | 246 | - | - | |
Ahy3g2033 | 338 | CDD | SANT | 71 | 112 | IPR001005 | - | |
Ahy3g2033 | 338 | SMART | sant | 13 | 63 | IPR001005 | - | |
Ahy3g2033 | 338 | SMART | sant | 66 | 114 | IPR001005 | - | |
Ahy3g2033 | 338 | Gene3D | - | 14 | 66 | - | - | |
Ahy3g2033 | 338 | SUPERFAMILY | Homeodomain-like | 12 | 108 | IPR009057 | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Ahy3g2033 | Ahy-Chr3 | 46235904 | 46238437 | Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Ahy3g2033 | 1 | 167 | MYB Transcription Factor Family | AT4G38620 | 54.651 | 1.51e-62 | 199 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
TF | MYB | Ahy3g2033 | Myb_DNA-binding | 1.90E-14 | CL0123 |
Select | Gene_1 | Chr_1 | Start_1 | End_1 | Gene_2 | Chr_2 | Start_2 | End_2 | Event_name |
---|---|---|---|---|---|---|---|---|---|
Ahy13g2320 | 13 | 49754471 | 49757631 | Ahy3g2033 | 3 | 46235904 | 46238437 | hybridization | |
Ahy3g2033 | 3 | 46235904 | 46238437 | Ahy11g3160 | 11 | 149167157 | 149168948 | PCT | |
Ahy3g2033 | 3 | 46235904 | 46238437 | Ahy1g1794 | 1 | 94234285 | 94236385 | PCT |